Abstract
Only a subset of hierarchically arranged, primitive human AML progenitor cells can initiate the disease in transplanted immune-deficient mice. A publication in Nature Biotechnology by Ishikawa et al. (2007) describes a new animal model to study chemotherapy-resistant, quiescent human AML CD34+CD38- stem cells, which are retained in the endosteum region.
Original language | English |
---|---|
Pages (from-to) | 483-484 |
Number of pages | 2 |
Journal | Cell Stem Cell |
Volume | 1 |
Issue number | 5 |
DOIs | |
State | Published - 15 Nov 2007 |
Externally published | Yes |